Benjamin F. Edwards & Company’s Globus Medical GMED Stock Holding History

Benjamin F. Edwards & Company’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$29K	Sell	416 -21	-5%	-$1.25K	﹤0.01%	1456
2024 Q1	$23K	Buy	437 +210	+93%	+$11.3K	﹤0.01%	1491
2023 Q4	$12K	Hold	227	–	–	﹤0.01%	1610
2023 Q3	$11K	Hold	227	–	–	﹤0.01%	1371
2023 Q2	$14K	Hold	227	–	–	﹤0.01%	1352
2023 Q1	$13K	Hold	227	–	–	﹤0.01%	1360
2022 Q4	$17K	Hold	227	–	–	﹤0.01%	1310
2022 Q3	$14K	Hold	227	–	–	﹤0.01%	1321
2022 Q2	$13K	Sell	227 -282	-55%	-$18.5K	﹤0.01%	1321
2022 Q1	$38K	Hold	509	–	–	﹤0.01%	1091
2021 Q4	$37K	Hold	509	–	–	﹤0.01%	1109
2021 Q3	$39K	Buy	509 +1	+0.2%	+$80	﹤0.01%	1082
2021 Q2	$39K	Hold	508	–	–	﹤0.01%	1079
2021 Q1	$31K	Hold	508	–	–	﹤0.01%	1111
2020 Q4	$33K	Sell	508 -1,100	-68%	-$63.2K	﹤0.01%	1060
2020 Q3	$80K	Buy	1,608 +926	+136%	+$47.8K	0.01%	797
2020 Q2	$33K	Buy	682 +400	+142%	+$19.3K	﹤0.01%	971
2020 Q1	$12K	Hold	282	–	–	﹤0.01%	1204
2019 Q4	$17K	Hold	282	–	–	﹤0.01%	1279
2019 Q3	$14K	Hold	282	–	–	﹤0.01%	1299
2019 Q2	$12K	Sell	282 -25	-8%	-$1.09K	﹤0.01%	1353
2019 Q1	$15K	Sell	307 -18	-6%	-$814	﹤0.01%	1211
2018 Q4	$14K	Sell	325 -25	-7%	-$1.25K	﹤0.01%	1184
2018 Q3	$20K	Sell	350 -15	-4%	-$789	﹤0.01%	1110
2018 Q2	$18K	Buy	365 +200	+121%	+$10.4K	﹤0.01%	1125
2018 Q1	$8K	Buy	+165	New	+$7.75K	﹤0.01%	1315

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BAM

Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Benjamin F. Edwards & Company's GMED Position: Q2 2024 in Review

Benjamin F. Edwards & Company reduced its Globus Medical (GMED) stake by 4.8% in Q2 2024, selling an estimated $1.25K and leaving 416 shares worth $29K. The position accounts for ﹤0.01% of the portfolio, ranked #1456.

Benjamin F. Edwards & Company first reported a position in GMED in Q1 2018 and has held it in 26 quarters since. The position peaked at $80K in Q3 2020. 450 funds tracked by Wall St. Rank hold GMED as of Q2 2024.

Benjamin F. Edwards & Company held 416 shares of Globus Medical worth $29K as of Q2 2024.
Benjamin F. Edwards & Company sold 21 Globus Medical shares in Q2 2024, an estimated $1.25K.
Globus Medical made up ﹤0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #1456 holding.
Benjamin F. Edwards & Company first reported a position in Globus Medical in Q1 2018 and has held it in 26 quarters since.
Benjamin F. Edwards & Company's Globus Medical position peaked at $80K in Q3 2020.
450 funds tracked by Wall St. Rank held Globus Medical as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.